Highlights:

• A development milestone boosted revenue, but recurring commercial income remains ahead.
• Cash rose to AU$180.74 million as Silex prepared for further testing.
• The planned Paducah facility faces crucial technical and regulatory steps.

Silex Systems Limited (ASX: SLX) announced its FY26 results on 27 August 2026, reporting a substantial revenue increase and a narrower loss. The figures reflect progress in its laser enrichment program, although the technology has yet to generate revenue from a commercial uranium production facility.

Milestone Payment Shapes the Results

Revenue from ordinary activities reached AU$21.59 million in FY26, up 76.9% compared to AU$12.20 million in FY25. That increase included AU$7.60 million recognised after Silex’s US venture, Global Laser Enrichment (GLE), achieved a major technology milestone in October 2025.

The annual net loss eased to AU$38.62 million, compared to AU$42.56 million previously. Development costs remain significant: Silex’s share of GLE’s loss increased as the venture expanded work on bringing the enrichment process closer to commercial use.

Cash and term deposits stood at AU$180.74 million on 30 June 2026, compared to AU$80.56 million a year earlier. The stronger balance largely reflects funds raised during the financial year. Silex had no corporate debt and did not declare a dividend.

Next Step for the Paducah Facility

Silex holds a 51% interest in GLE, which is developing a proposed uranium enrichment facility in Paducah, Kentucky. Following its independently assessed pilot demonstration, GLE is working on full-scale equipment and manufacturing processes. These tests will help establish whether the technology can perform reliably in a production setting.

GLE is also pursuing the US licence needed to build and operate the facility. It expects the regulatory process to continue into early 2027. A feasibility assessment and final investment decision are additional steps before construction can proceed.

Outlook: Proof of Commercial Readiness

GLE aims to start operations at Paducah by 2030, but that date remains conditional on technical results, regulatory approval, project economics and funding. Silex is separately preparing to produce initial samples of enriched silicon for potential quantum computing applications in the first quarter of 2027.

For investors, the stronger cash balance supports the next phase of work. The key question is whether upcoming tests and approvals can turn demonstrated technical progress into a viable commercial business.

Note- All data presented is based on information available at the time of writing.

Disclaimer for Kapitales Research

The materials provided by Kapitales Research, including articles, news, data, reports, opinions, images, charts, and videos ("Content"), are intended for personal, non-commercial use only. The primary goal of this Content is to educate and inform readers. This Content is not meant to offer financial advice, nor does it include any recommendation or opinion that should be relied upon for making financial decisions. Certain Content on this platform may be sponsored or unsponsored, but it does not serve as a solicitation or endorsement to buy, sell, or hold any securities, nor does it encourage any specific investment activities. Kapitales Research is not authorized to provide investment advice, and we strongly advise users to seek guidance from a qualified financial professional, such as a financial advisor or stockbroker, before making any investment choices. Kapitales Research disclaims all liability for any direct, indirect, incidental, or consequential damages arising from the use of the Content, which is provided without any warranties. The opinions expressed by contributors or guests are their own and do not necessarily reflect the views of Kapitales Research. Media such as images or music used on this platform are either owned by Kapitales Research, sourced through paid subscriptions, or believed to be in the public domain. We have made reasonable efforts to credit sources where appropriate. Kapitales Research does not claim ownership of any third-party media unless explicitly stated otherwise.

.  

Customer Notice:

Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.Disclosure: The information mentioned above has been sourced from the company reports and a third-party database, i.e. Koyfin. Investors are advised to use strict stop-loss to protect their investments in case of any unfavorable/uncertain market events.

Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au